3E Bioventures in Cell & Gene Therapy Solutions
18 Jun 2024
US$ 19.00
3E Bioventures Capital has led the near Rmb200 million (US$27.6 million) series B funding round of Shenzhen Cellbri ......
Tag
Biotech
Related Publications
Subscribers’ Weekly...
Listen to Australia/New Zealand Investments (Subscribers' Weekly 05 Jul 2024)...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.